Respiri Limited (AU:RSH) has released an update.
Respiri Limited reported significant growth in patient program enrollments and revenue for the September 2024 quarter, with a 71% increase in enrollments and a 93% rise in revenues compared to the previous quarter. The company also strengthened partnerships and expanded client base, which are expected to further boost revenues and support their goal of achieving monthly profitability. The streamlined onboarding process and strategic partnerships, notably with Ceras Healthcare, are driving operational efficiencies and positioning Respiri for continued expansion in the healthcare market.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
